Pharmacy

Jul 14 2018

Pharmaceutical Technologies NZ Supplement Formulation Development, pharmaceutical formulation.#Pharmaceutical #formulation

Are you a small to medium enterprise working in the Nutraceuticals, supplement or cosmetic industries? Pharmatech offer C omprehensive Technical Services PETER LEHRKE FOUNDER MANAGING DIRECTOR Pharmatech was founded in 2003 by biochemist Peter Lehrke, who saw the need that small to medium sized food, supplement and cosmetic companies had for professional technical support. Having worked in the pharmaceutical industry for a large part of his career, Peter learnt the methods used by multi-national companies to develop new products, project manage complex technical projects such as innovative research projects, new factory design and build projects, and introduction of new technologies. …

Jun 10 2018

Pharma Machinery, Pharmaceuticals Machinery, Pharmaceuticals Machines, pharmaceutical formulation companies.#Pharmaceutical #formulation #companies

Prism Pharma Machinery, Pharmaceuticals Machinery, Pharma Machines Manufacturer, Manufacturers Exporters of Pharmaceutical Machinery Welcome our Website Prism Pharma Machinery founded in 2003 and has been manufacturing Process equipment for Pharmaceuticals, Nutraceuticals, Biotech, Foods, Cosmetics, Bakery, Dairy, Confectionery, Agro Chemical, Chemical, Paint, Herbals, Ceramics , Catalysts for production, pilot lab scale. The Prism Pharma Machinery is having world’s largest range for process equipments. The company is known for innovative manufacturer for processing system for drying, granulating, mixing, milling, size reducing, blending, tabletting, coating, pelletizing, pellet coating, stirring, homogenizing, Vacuumised mixing, filtration, evaporation, containment, material conveying, cleaning and fermentation as well as …

Mar 12 2018

Pharmaceutical Drug Formulation, Development & Drug Delivery, pharmaceutical formulation.#Pharmaceutical #formulation

Formulation Drug Delivery Technologies Drug product formulation is at the core of Particle Sciences. Industry-wide, delivery of active pharmaceutical ingredients (APIs) has taken center stage along with the API’s themselves. Focused initially on problematic new chemical entities (NCEs), delivery systems are now the go-to approach for both NCE commercialization and the refinement and repurposing of existing APIs. The biological and chemical needs generally fall into one or a combination of a small number of categories. In addition to physicochemical and physiologic goals, business concerns also drive the use of sophisticated drug delivery systems. Intellectual property, life-cycle management, cost and market …

Mar 12 2018

Pharmaceutical Formulation Development – preformulation to clinical trial formulation, pharmaceutical formulation.#Pharmaceutical #formulation

Formulation Development The Complete Formulation Development Service When you move from discovery to development the process will involve: Preformulation – assessing solubility, stability, physical form etc Selection of the best form – salt / polymorph Developability screen Development of a preclinical formulation Development of a phase 1 clinical trial formulation Development of later phase clinical trial formulations and finally adaptation of this to a commercial form Pharmaterials can help with every step on this path: All with Pharmaterials in our facility with the same staff involved throughout. Solid Oral Dosage Forms Pharmaterials offers a range of conventional approaches for formulation: …

Mar 7 2018

Solubility profile, Stability profile, Reformulation, 505(b)2, Deformulation, pharmaceutical formulation companies.#Pharmaceutical #formulation #companies

pharmaceutical formulation companies Welcome to LATITUDE Pharmaceuticals Formulation Experts for Insoluble Compounds LATITUDE Pharmaceuticals Inc. is a leading-edge boutique contract research organization that provides innovative drug formulation services and proprietary drug delivery systems to the human and veterinary pharmaceutical industries. Since our founding in 2003, we have performed over 750 formulation development projects for over 200 client companies and have developed a world-wide reputation for creative approaches, reliability, rapid turnaround, successful formulations and client satisfaction. LATITUDE’s focus is on the special challenges of formulation development for compounds that are highly insoluble, highly unstable, and/or have poor bioavailability. This focus has …

Jan 22 2018

Pharmaceutical Technologies NZ Supplement Formulation Development, pharmaceutical formulation development.#Pharmaceutical #formulation #development

Are you a small to medium enterprise working in the Nutraceuticals, supplement or cosmetic industries? Pharmatech offer C omprehensive Technical Services PETER LEHRKE FOUNDER MANAGING DIRECTOR Pharmatech was founded in 2003 by biochemist Peter Lehrke, who saw the need that small to medium sized food, supplement and cosmetic companies had for professional technical support. Having worked in the pharmaceutical industry for a large part of his career, Peter learnt the methods used by multi-national companies to develop new products, project manage complex technical projects such as innovative research projects, new factory design and build projects, and introduction of new technologies. …

Jan 20 2018

Pharmaceutical Manufacturing and Exports, Research and Development in Pharma, pharmaceutical formulation.#Pharmaceutical #formulation

pharmaceutical formulation THROUGH TRUST SINGLE PRODUCT FILED IN 25 COUNTRIES THROUGH GROWTH 40% TOPLINE GROWTH IN THE LAST 4 YEARS THROUGH PARTNERSHIP ASSOCIATED WITH THE UNO FOR DEVELOPMENT OF ARVS THROUGH CAPABILITY 4900 KL REACTION CAPABILITY, 55 TYPES OF REACTION AUROBINDO’S WORKFORCE IS MAKING TOMORROW POSSIBLE OVER 14500 EMPLOYEES FROM 26 COUNTRIES Aurobindo is one of the top API manufacturing companies.. Read More formulations Formulations One of the largest vertically in. Read More Custom Synthesis Custom Synthesis AuroSource is the Custom. Read More ARVs / HIVs We aim to achieve the goals for wider access. Read More PEPTIDES Auro Peptides …

Jan 20 2018

Pharmaceutical Drug Formulation, Development & Drug Delivery, pharmaceutical formulation.#Pharmaceutical #formulation

Formulation Drug Delivery Technologies Drug product formulation is at the core of Particle Sciences. Industry-wide, delivery of active pharmaceutical ingredients (APIs) has taken center stage along with the API’s themselves. Focused initially on problematic new chemical entities (NCEs), delivery systems are now the go-to approach for both NCE commercialization and the refinement and repurposing of existing APIs. The biological and chemical needs generally fall into one or a combination of a small number of categories. In addition to physicochemical and physiologic goals, business concerns also drive the use of sophisticated drug delivery systems. Intellectual property, life-cycle management, cost and market …

Jan 20 2018

Oral Solid Dosage Pharmaceutical Formulation Market – Global Industry Analysis, Size and Forecast, 2017 to 2027, pharmaceutical formulation.#Pharmaceutical #formulation

Oral Solid Dosage Pharmaceutical Formulation Market Segmentation By Dosage Form – Tablets, Capsules, Powders, Others; By Drug Release Mechanism – Immediate Release, Extended Release (Sustained Release, Controlled Release), Others; By Distribution Channel – Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy Oral Solid Dosage Pharmaceutical Formulation Market: Emerging Markets of Latin America, APEJ and MEA to Collectively Hold over 45% Market Value Share: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027 REP-GB-2782 2017-07-18 195 Pages Format: Category:Healthcare, Pharmaceuticals and Medical devices Future Market Insights forecasts the global oral solid dosage pharmaceutical formulation market to grow from …

Jan 20 2018

Solubility profile, Stability profile, Reformulation, 505(b)2, Deformulation, pharmaceutical formulation.#Pharmaceutical #formulation

pharmaceutical formulation Welcome to LATITUDE Pharmaceuticals Formulation Experts for Insoluble Compounds LATITUDE Pharmaceuticals Inc. is a leading-edge boutique contract research organization that provides innovative drug formulation services and proprietary drug delivery systems to the human and veterinary pharmaceutical industries. Since our founding in 2003, we have performed over 750 formulation development projects for over 200 client companies and have developed a world-wide reputation for creative approaches, reliability, rapid turnaround, successful formulations and client satisfaction. LATITUDE’s focus is on the special challenges of formulation development for compounds that are highly insoluble, highly unstable, and/or have poor bioavailability. This focus has made …

Nov 13 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #global #pharmaceutical #companies

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Jul 31 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #manufacturing #magazine

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

May 13 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #jamjoom #pharma

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Apr 18 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharma #medical

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Mar 15 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #eisai #pharma

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Feb 11 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #italian #pharmaceutical #companies

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Jan 22 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #healthcare #companies

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Nov 11 2016

Endo Pharma to withdraw application for new opioid painkiller formulation #global #pharm

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Nov 1 2016

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #manufacturing

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Oct 26 2016

Endo Pharma to withdraw application for new opioid painkiller formulation #rexall #pharma #plus

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Oct 4 2016

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #market

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …